journal article·2022-11-01Open access

PBPK modelling of ceftriaxone Na-loaded starch-sodium alginate polymeric blend prepared by water-in-oil emulsification for oral delivery

Hina Raza, Yusra Ilahi, Zermina Rashid, Shabnam Nazir, Suryyia Manzoor, Mohamed Deifallah Yousif

Materials Research Express· Volume 9· Issue 11

Abstract

Abstract Ceftriaxone is a third-generation cephalosporin antibiotic effective against many bacterial infections. However, owing to its instability in the gastrointestinal tract (GIT), it is administered by injections, which is an unfavourable route of administration. Therefore, the aim of this study was to formulate ceftriaxone into biodegradable and thermally stable polymeric blend microparticles that are suitable for oral delivery. The drug-loaded microparticles were prepared by the water-in-oil (W/O) emulsion method and consisted of starch and sodium alginate (NaAlg) as a polymeric matrix and glutaraldehyde (GA) as a cross-linking agent. Characterization of these particles using scanning electron microscopy (SEM) showed that the particles were spherical in shape with a smooth surface. Differential scanning calorimetry (DSC) and X-ray diffraction (XRD) of these particles showed no drug-polymer interactions. The highest percentage yield of particles was obtained at 3% polymer concentration. The particle size increased slightly after drug loading. The drug loading and entrapment efficiency appeared to increase with increasing polymer concentration. In vitro drug release at pH 1.2 and pH 7.4, revealed that drug release was below 20% at the acidic pH, while at pH 7.4, drug release of up to 85% was observed. The release mechanism followed first-order and Fickian diffusion patterns. Plasma concentration-time profiles were simulated for subcontinental Asian populations using commercial PBPK software, and the results suggest that microencapsulation of ceftriaxone sodium in a polymeric blend could represent a promising approach for controlled oral delivery of the drug, with enhanced absorption and bioavailability of the drug.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems · Antibiotics Pharmacokinetics and Efficacy

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Controlled release drug delivery systems10.1080/10837450.2018.1534376 ↗
2. Oral controlled drug delivery and delivery systems
3. Preparation and diffusional evaluation of sustained - Release suppositories containing ibuprofen microspheres
4. Microsphere: a brief review10.15272/ajbps.v5i47.713 ↗
5. Natural polymers—a comprehensive review
6. Starch-based completely biodegradable polymer materials10.3144/expresspolymlett.2009.46 ↗
7. Starch acetate as a tablet matrix for sustained drug release10.1016/j.jconrel.2003.09.017 ↗
8. Preparation and in vitro release of theophylline loaded sodium alginate microspheres
9. Glutaraldehyde crosslinked sodium alginate beads containing liquid pesticide for soil application10.1016/S0168-3659(99)00176-5 ↗
10. Protein release from alginate matrices10.1016/S0169-409X(97)00124-5 ↗
11. Cross-linked alginate-gelatine beads: a new matrix for controlled release of pindolol10.1016/j.jconrel.2004.03.015 ↗
12. Enhancement of the intestinal absorption of peptides and non-peptides10.1016/0168-3659(96)01353-3 ↗
13. Preparation and characterization of ceftriaxone sodium encapsulated chitosan nanoparticles10.22159/ijap.2017v9i6.16317 ↗
14. Cationic analog of deoxycholate as an oral delivery carrier for ceftriaxone
15. Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates10.1007/s11095-012-0932-0 ↗
16. New perspective enteric-coated tablet dosage form for oral administration of ceftriaxone: In Vitro and In Vivo assessments10.1208/s12249-019-1512-y ↗
17. Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium10.3109/10717540903334959 ↗
18. Development and characterization of ceftriaxone-loaded P3HB-based microparticles for drug delivery10.1080/07373937.2018.1487451 ↗
19. Galactosylated iron oxide nanoparticles for enhancing oral bioavailability of ceftriaxone10.1080/10837450.2020.1866602 ↗
20. Mechanistic study on hydration and drug release behavior of sodium alginate compacts10.1080/03639040600943814 ↗
21. Aspects of the preparation of starch microcellular foam particles crosslinked with glutaraldehyde using a solvent exchange technique10.1016/j.carbpol.2006.05.029 ↗
22. Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers10.1007/s10856-006-8240-z ↗
23. Sodium alginate and its blends with starch: thermal and morphological properties10.1002/app.28625 ↗
24. Development of starch-gelatin complex microspheres as sustained release delivery system10.4103/2231-4040.101015 ↗
25. Poly(ethylene oxide) and its blends with sodium alginate10.1016/j.polymer.2005.09.041 ↗
26. Calcium alginate-carboxymethyl cellulose beads for colon-targeted drug delivery10.1016/j.ijbiomac.2014.12.052 ↗
27. Spectral measurements and qualitative analysis of ceftriaxone and cefotaxime
28. Alginate/graphene oxide fibres with enhanced mechanical strength prepared by wet spinning10.1016/j.carbpol.2012.01.071 ↗
29. Morphological analysis of the antimicrobial action of silver and gold nanoparticles stabilized with ceftriaxone on Escherichia coli using atomic force microscopy10.1039/C4NJ00751D ↗
30. Soluble starch-blended Ca 2 + -Zn 2 + -alginate composites-based microparticles of aceclofenac: Formulation development and in vitro characterization10.1016/j.fjps.2017.10.001 ↗
31. Novel Starch-PVA polymer for microparticle preparation and optimization using factorial design study10.1155/2015/261476 ↗
32. Pectin-gelatin and alginate-gelatin complex coacervation for controlled drug delivery: Influence of anionic polysaccharides and drugs being encapsulated on physicochemical properties of microcapsules10.1016/j.carbpol.2009.12.036 ↗
33. Alginate/starch blend fibers and their properties for drug controlled release10.1016/j.carbpol.2010.06.004 ↗
34. Infrared spectroscopy as a tool to characterise starch ordered structure - a joint FTIR-ATR, NMR, XRD and DSC study10.1016/j.carbpol.2015.11.066 ↗
35. Characterization of antibiotic-loaded alginate-osa starch microbeads produced by ionotropic pregelation10.1155/2013/472626 ↗
36. Comparison of the dissolution rate of ceftriaxone sodium preparations for injection10.1248/cpb.c13-00428 ↗
37. Control of encapsulation efficiency and initial burst in polymeric microparticle systems10.1007/BF02980037 ↗
38. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems10.1016/j.ijpharm.2008.01.030 ↗
39. Furosemide-loaded alginate microspheres prepared by ionic cross-linking technique: morphology and release characteristics10.4103/0250-474X.40336 ↗
40. Smart porous microparticles based on gelatin/sodium alginate polyelectrolyte complex10.1016/j.jfoodeng.2013.02.018 ↗
41. Properties of fatty-acid esters of starch and their blends with LDPE
42. Thermal characterization of rice starches: a polymeric approach to phase transitions of granular starch10.1021/jf00067a002 ↗
43. Morphology and thermal stability of silk fibroin/ starch blended microparticles10.3144/expresspolymlett.2010.94 ↗
44. Development and evaluation of a calcium alginate based oral ceftriaxone sodium formulation10.1007/s40204-016-0051-9 ↗
45. Fabrication and in vitro evaluation of 5-florouracil loaded chondroitin sulfate-sodium alginate microspheres for colon-specific delivery
46. Poly(vinyl alcohol) and poly(acrylic acid) sequential interpenetrating network pH-sensitive microspheres for the delivery of diclofenac sodium to the intestine10.1016/j.jconrel.2003.12.025 ↗
47. Sodium alginate microspheres of metformin HCl: formulation and In Vitro evaluation10.2174/156720107781023875 ↗
48. Sweet potato starch microparticles as controlled drug release carriers: preparation and in vitro drug release10.1080/07373930701290977 ↗
49. determination of variation in flow property of different formulas of starch along with amlodipine and propranolol